The Network Operating EBITDA improved to Rs 364 crore compared to Rs 253 crore in the corresponding quarter last year
Max Healthcare Institute has announced its financial results for the three months ended December 31, 2021. The network gross revenue stood at Rs 1,392 crore during the third quarter reflecting a growth of 20 per cent YoY. This includes Rs 7 crore from COVID-19 vaccinations during the quarter, compared to Rs 91 Crore in Q2 FY22. Gross revenue excluding COVID-19 vaccination & related antibody tests, thus, grew by 20 per cent YoY and 3 per cent QoQ, despite it being a seasonally lean quarter for healthcare services.
The Network Operating EBITDA improved to Rs 364 crore compared to Rs 253 crore in the corresponding quarter last year and Rs 362 crore in the previous quarter (Q2 FY22). This is the highest ever quarterly Operating EBITDA and represents the fifth consecutive quarter of EBITDA growth. The Operating EBITDA margin stood at 27.6 per cent for the quarter, up from 23.2% in the corresponding period in FY21 and 26.8 per cent in Q2 FY22. The Operating EBITDA2 per bed grew by 9 per cent QoQ. Profit after tax for the quarter stood at Rs 252 crore compared to Rs 135 crore in Q3 last year and Rs 207 crore in Q2 FY22.
The revenue from international medical tourism improved to Rs 77 crore during the quarter – a rise of 68 per cent over Q2 FY22. However, the same represents 2/3rd of the pre-covid run rate, owing to continued air-travel related restrictions.
